COMBINATORX
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.
COMBINATORX
Industry:
Biotechnology Health Care
Founded:
2000-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
70 M USD
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Investors List
Boston Millennia Partners
Boston Millennia Partners investment in Series C - CombinatoRx
Global Life Science Ventures
Global Life Science Ventures investment in Series C - CombinatoRx
Flagship Pioneering
Flagship Pioneering investment in Series C - CombinatoRx
TL Ventures
TL Ventures investment in Series C - CombinatoRx
Canaan Partners
Canaan Partners investment in Series C - CombinatoRx
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series C - CombinatoRx
Flagship Pioneering
Flagship Pioneering investment in Series B - CombinatoRx
More informations about "CombinatoRx"
Zalicus - Crunchbase Company Profile & Funding
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the …See details»
CombinatoRx Company Profile | Management and Employees List
CombinatoRx, Incorporated (CRXX) is pioneering the new field of synergistic combination pharmaceuticals and has a broad product portfolio in phase 2 clinical development. Going …See details»
Alexis Borisy - Innovators Under 35
Organization CombinatoRX Region Global ... CombinatoRx examines compounds two at a time, in different doses, answering that question 36 separate times. Borisy says the company had to …See details»
CombinatoRx - Overview, News & Similar companies - ZoomInfo
Who is CombinatoRx. CombinatoRx, Incorporated (CRXX) is pioneering the new field of synergistic combination pharmaceuticals and has a broad product portfolio in phase 2 clinical …See details»
CombinatoRx - Funding, Financials, Valuation & Investors
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How …See details»
CombinatoRx - Flagship Pioneering
CombinatoRx, founded in 2002, was a publicly-traded biopharmaceutical company pioneering the field of synergistic combination pharmaceuticals. The company’s approach centered on …See details»
Profile: Alexis Borisy - Nature Biotechnology
May 1, 2006 Cut to the present: CombinatoRx's plush, new digs in Cambridge house a state-of-the-art, robotic platform. Nearly 10 million screened combinations in several disease …See details»
Horizon to Acquire CombinatoRx Service Business and Assets from …
May 15, 2014 The new services offered by Horizon CombinatoRx address this need by providing a scalable, high throughput combination screening platform, alongside Horizon’s gene editing …See details»
CombinatoRx - VentureRadar
CombinatoRx is pioneering the new field of synergistic combination pharmaceuticals, that is, combining drugs already approved by the FDA to create new applications. The CombinatoRx …See details»
Horizon Completes Acquisition of CombinatoRx from Zalicus
Jun 2, 2014 Horizon Discovery Group plc announces it has completed the acquisition of the CombinatoRx service business (known as the combination high throughput screening (cHTS) …See details»
CombinatoRx - Products, Competitors, Financials, Employees ...
CombinatoRx is a Cambridge, Massachusetts-based Healthcare company. Use the CB Insights Platform to explore CombinatoRx's full profile. CombinatoRx - Products, Competitors, …See details»
Horizon completes acquisition of CombinatoRx Service business, …
The new business will become Horizon CombinatoRx Incorporated, a wholly owned subsidiary of Horizon. Horizon CombinatoRx, Inc. will be located in 23,000 sq. ft. of laboratory and office …See details»
CombinatoRx - Canaan
CombinatoRx is pioneering the new field of synergistic combination pharmaceuticals, that is, combining drugs already approved by the FDA to create new applications. The CombinatoRx …See details»
The right combination - Nature
Jan 25, 2005 CombinatoRx (pronounced Combinatorix) is the brainchild of Harvard chemistry PhD dropout Alexis Borisy and several pals, all of whom worked in the lab of leading chemical …See details»
CombinatoRx and Neuromed Sign Merger Agreement
Jul 6, 2009 CombinatoRx, Incorporated and Neuromed Pharmaceuticals, Inc. announced they have entered into a definitive merger agreement under which CombinatoRx and Neuromed will …See details»
CombinatoRx Concentrates on Core Strengths | Fierce Biotech
Nov 21, 2008 CombinatoRx Concentrates on Core Strengths -- Focuses Business Model on Technology Platform - CAMBRIDGE, Mass.--(BUSINESS WIRE)--CombinatoRx, Incorporated …See details»
Emerging Drug Developer: CombinatoRx | Fierce Biotech
Year ahead will put CombinatoRx’s discovery model to the test  Alexis Borisy doesn’t think small. A lead development program in osteoarthritis and rheumatoid arthritis can attract theSee details»
Jacob Goldfield - Chairman @ CombinatoRx - Crunchbase
Jacob is a successful option trader who retired as a senior partner of Goldman Sachs. He was later the CIO of Soros Fund Management and Quantum before starting his own firm. He has …See details»
What is CombinatoRx? Company Culture, Mission, Values
CombinatoRx. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim your Free …See details»